ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for No-Reflow Phenomenon

  • Rivaroxaban for Slow Coronary Flow After PCI in STEMI
  • Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
  • The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
  • Empagliflozin for No-reflow Phenomenon in PCI for STEMI
  • A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
  • Alpha Lipoic Acid Effect on No-Reflow Phenomenon
  • Adrenaline for the Treatment of No-Reflow in Normotensive Patients
  • The EPIVER Randomized Controlled Trial
  • Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
  • Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
  • Intracoronary Tirofiban on No-Reflow Phenomena
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group